Datoselskabet Horsens af 28.08.2017 ApS — Credit Rating and Financial Key Figures
CVR number: 37053759
Havnegade 4, 5000 Odense C
info@reconpharma.com
tel: 91258145
www.reconpharma.com
Income statement (kDKK)
2016 | 2017 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | - 510.05 | 80.54 |
Employee benefit expenses | - 206.35 | -36.87 |
Other operating expenses | - 289.43 | |
EBIT | - 716.39 | - 245.75 |
Other financial income | 3.37 | |
Other financial expenses | -40.62 | -0.60 |
Net income from associates (fin.) | -50.00 | |
Pre-tax profit | - 753.65 | - 296.35 |
Net earnings | - 753.65 | - 296.35 |
Assets (kDKK)
2016 | 2017 | |
---|---|---|
Development expenditure | 1 303.23 | |
Intangible assets total | 1 303.23 | |
Tangible assets total | ||
Holdings in group member companies | 50.00 | |
Investments total | 50.00 | |
Long term receivables total | ||
Finished products/goods | 79.12 | |
Inventories total | 79.12 | |
Current amounts owed by group member comp. | 0.60 | |
Current other receivables | 36.87 | |
Short term receivables total | 36.87 | 0.60 |
Cash and bank deposits | 40.25 | |
Cash and cash equivalents | 40.25 | |
Balance sheet total (assets) | 1 509.46 | 0.60 |
Equity and liabilities (kDKK)
2016 | 2017 | |
---|---|---|
Share capital | 65.00 | 65.00 |
Share premium account | 985.00 | 985.00 |
Other reserves | 1 303.23 | |
Retained earnings | -1 303.23 | - 753.65 |
Profit of the financial year | - 753.65 | - 296.35 |
Shareholders equity total | 296.35 | |
Non-current liabilities total | ||
Current loans from credit institutions | 16.12 | |
Current trade creditors | 30.00 | 0.60 |
Current owed to participating | 1 027.92 | |
Current owed to group member | 19.55 | |
Other non-interest bearing current liabilities | 119.52 | |
Current liabilities total | 1 213.11 | 0.60 |
Balance sheet total (liabilities) | 1 509.46 | 0.60 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.